Global DNA Damage Response Drugs Market Size, Status and Forecast 2024-2031

Report ID: 919057 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global DNA Damage Response Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Lynparza
        1.2.3 Talzenna
        1.2.4 Zejula
        1.2.5 Rubraca
    1.3 Market by Application
        1.3.1 Global DNA Damage Response Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Ovarian Cancer
        1.3.3 Breast Cancer
        1.3.4 Pancreatic Cancer
        1.3.5 Prostate Cancer
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global DNA Damage Response Drugs Market Perspective (2016-2027)
    2.2 DNA Damage Response Drugs Growth Trends by Regions
        2.2.1 DNA Damage Response Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 DNA Damage Response Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 DNA Damage Response Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 DNA Damage Response Drugs Industry Dynamic
        2.3.1 DNA Damage Response Drugs Market Trends
        2.3.2 DNA Damage Response Drugs Market Drivers
        2.3.3 DNA Damage Response Drugs Market Challenges
        2.3.4 DNA Damage Response Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top DNA Damage Response Drugs Players by Revenue
        3.1.1 Global Top DNA Damage Response Drugs Players by Revenue (2016-2021)
        3.1.2 Global DNA Damage Response Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global DNA Damage Response Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by DNA Damage Response Drugs Revenue
    3.4 Global DNA Damage Response Drugs Market Concentration Ratio
        3.4.1 Global DNA Damage Response Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by DNA Damage Response Drugs Revenue in 2020
    3.5 DNA Damage Response Drugs Key Players Head office and Area Served
    3.6 Key Players DNA Damage Response Drugs Product Solution and Service
    3.7 Date of Enter into DNA Damage Response Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 DNA Damage Response Drugs Breakdown Data by Type
    4.1 Global DNA Damage Response Drugs Historic Market Size by Type (2016-2021)
    4.2 Global DNA Damage Response Drugs Forecasted Market Size by Type (2022-2027)

5 DNA Damage Response Drugs Breakdown Data by Application
    5.1 Global DNA Damage Response Drugs Historic Market Size by Application (2016-2021)
    5.2 Global DNA Damage Response Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America DNA Damage Response Drugs Market Size (2016-2027)
    6.2 North America DNA Damage Response Drugs Market Size by Type
        6.2.1 North America DNA Damage Response Drugs Market Size by Type (2016-2021)
        6.2.2 North America DNA Damage Response Drugs Market Size by Type (2022-2027)
        6.2.3 North America DNA Damage Response Drugs Market Size by Type (2016-2027)
    6.3 North America DNA Damage Response Drugs Market Size by Application
        6.3.1 North America DNA Damage Response Drugs Market Size by Application (2016-2021)
        6.3.2 North America DNA Damage Response Drugs Market Size by Application (2022-2027)
        6.3.3 North America DNA Damage Response Drugs Market Size by Application (2016-2027)
    6.4 North America DNA Damage Response Drugs Market Size by Country
        6.4.1 North America DNA Damage Response Drugs Market Size by Country (2016-2021)
        6.4.2 North America DNA Damage Response Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe DNA Damage Response Drugs Market Size (2016-2027)
    7.2 Europe DNA Damage Response Drugs Market Size by Type
        7.2.1 Europe DNA Damage Response Drugs Market Size by Type (2016-2021)
        7.2.2 Europe DNA Damage Response Drugs Market Size by Type (2022-2027)
        7.2.3 Europe DNA Damage Response Drugs Market Size by Type (2016-2027)
    7.3 Europe DNA Damage Response Drugs Market Size by Application
        7.3.1 Europe DNA Damage Response Drugs Market Size by Application (2016-2021)
        7.3.2 Europe DNA Damage Response Drugs Market Size by Application (2022-2027)
        7.3.3 Europe DNA Damage Response Drugs Market Size by Application (2016-2027)
    7.4 Europe DNA Damage Response Drugs Market Size by Country
        7.4.1 Europe DNA Damage Response Drugs Market Size by Country (2016-2021)
        7.4.2 Europe DNA Damage Response Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific DNA Damage Response Drugs Market Size (2016-2027)
    8.2 Asia-Pacific DNA Damage Response Drugs Market Size by Type
        8.2.1 Asia-Pacific DNA Damage Response Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific DNA Damage Response Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific DNA Damage Response Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific DNA Damage Response Drugs Market Size by Application
        8.3.1 Asia-Pacific DNA Damage Response Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific DNA Damage Response Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific DNA Damage Response Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific DNA Damage Response Drugs Market Size by Region
        8.4.1 Asia-Pacific DNA Damage Response Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific DNA Damage Response Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America DNA Damage Response Drugs Market Size (2016-2027)
    9.2 Latin America DNA Damage Response Drugs Market Size by Type
        9.2.1 Latin America DNA Damage Response Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America DNA Damage Response Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America DNA Damage Response Drugs Market Size by Type (2016-2027)
    9.3 Latin America DNA Damage Response Drugs Market Size by Application
        9.3.1 Latin America DNA Damage Response Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America DNA Damage Response Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America DNA Damage Response Drugs Market Size by Application (2016-2027)
    9.4 Latin America DNA Damage Response Drugs Market Size by Country
        9.4.1 Latin America DNA Damage Response Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America DNA Damage Response Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa DNA Damage Response Drugs Market Size (2016-2027)
    10.2 Middle East & Africa DNA Damage Response Drugs Market Size by Type
        10.2.1 Middle East & Africa DNA Damage Response Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa DNA Damage Response Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa DNA Damage Response Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa DNA Damage Response Drugs Market Size by Application
        10.3.1 Middle East & Africa DNA Damage Response Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa DNA Damage Response Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa DNA Damage Response Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa DNA Damage Response Drugs Market Size by Country
        10.4.1 Middle East & Africa DNA Damage Response Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa DNA Damage Response Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AbbVie Inc
        11.1.1 AbbVie Inc Company Details
        11.1.2 AbbVie Inc Business Overview
        11.1.3 AbbVie Inc DNA Damage Response Drugs Introduction
        11.1.4 AbbVie Inc Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.1.5 AbbVie Inc Recent Development
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Details
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca DNA Damage Response Drugs Introduction
        11.2.4 AstraZeneca Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.2.5 AstraZeneca Recent Development
    11.3 Bayer
        11.3.1 Bayer Company Details
        11.3.2 Bayer Business Overview
        11.3.3 Bayer DNA Damage Response Drugs Introduction
        11.3.4 Bayer Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.3.5 Bayer Recent Development
    11.4 BeiGene
        11.4.1 BeiGene Company Details
        11.4.2 BeiGene Business Overview
        11.4.3 BeiGene DNA Damage Response Drugs Introduction
        11.4.4 BeiGene Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.4.5 BeiGene Recent Development
    11.5 Clovis Oncology
        11.5.1 Clovis Oncology Company Details
        11.5.2 Clovis Oncology Business Overview
        11.5.3 Clovis Oncology DNA Damage Response Drugs Introduction
        11.5.4 Clovis Oncology Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.5.5 Clovis Oncology Recent Development
    11.6 Debiopharm
        11.6.1 Debiopharm Company Details
        11.6.2 Debiopharm Business Overview
        11.6.3 Debiopharm DNA Damage Response Drugs Introduction
        11.6.4 Debiopharm Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.6.5 Debiopharm Recent Development
    11.7 Eli Lilly and Company
        11.7.1 Eli Lilly and Company Company Details
        11.7.2 Eli Lilly and Company Business Overview
        11.7.3 Eli Lilly and Company DNA Damage Response Drugs Introduction
        11.7.4 Eli Lilly and Company Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.7.5 Eli Lilly and Company Recent Development
    11.8 GlaxoSmithKline
        11.8.1 GlaxoSmithKline Company Details
        11.8.2 GlaxoSmithKline Business Overview
        11.8.3 GlaxoSmithKline DNA Damage Response Drugs Introduction
        11.8.4 GlaxoSmithKline Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.8.5 GlaxoSmithKline Recent Development
    11.9 Merck
        11.9.1 Merck Company Details
        11.9.2 Merck Business Overview
        11.9.3 Merck DNA Damage Response Drugs Introduction
        11.9.4 Merck Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.9.5 Merck Recent Development
    11.10 NMS Group SpA
        11.10.1 NMS Group SpA Company Details
        11.10.2 NMS Group SpA Business Overview
        11.10.3 NMS Group SpA DNA Damage Response Drugs Introduction
        11.10.4 NMS Group SpA Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.10.5 NMS Group SpA Recent Development
    11.11 Onxeo
        11.11.1 Onxeo Company Details
        11.11.2 Onxeo Business Overview
        11.11.3 Onxeo DNA Damage Response Drugs Introduction
        11.11.4 Onxeo Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.11.5 Onxeo Recent Development
    11.12 Pfizer
        11.12.1 Pfizer Company Details
        11.12.2 Pfizer Business Overview
        11.12.3 Pfizer DNA Damage Response Drugs Introduction
        11.12.4 Pfizer Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.12.5 Pfizer Recent Development
    11.13 Repare Therapeutics
        11.13.1 Repare Therapeutics Company Details
        11.13.2 Repare Therapeutics Business Overview
        11.13.3 Repare Therapeutics DNA Damage Response Drugs Introduction
        11.13.4 Repare Therapeutics Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.13.5 Repare Therapeutics Recent Development
    11.14 Sierra Oncology
        11.14.1 Sierra Oncology Company Details
        11.14.2 Sierra Oncology Business Overview
        11.14.3 Sierra Oncology DNA Damage Response Drugs Introduction
        11.14.4 Sierra Oncology Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.14.5 Sierra Oncology Recent Development
    11.15 Zentalis Pharmaceuticals
        11.15.1 Zentalis Pharmaceuticals Company Details
        11.15.2 Zentalis Pharmaceuticals Business Overview
        11.15.3 Zentalis Pharmaceuticals DNA Damage Response Drugs Introduction
        11.15.4 Zentalis Pharmaceuticals Revenue in DNA Damage Response Drugs Business (2016-2021)
        11.15.5 Zentalis Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global DNA Damage Response Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Lynparza
    Table 3. Key Players of Talzenna
    Table 4. Key Players of Zejula
    Table 5. Key Players of Rubraca
    Table 6. Global DNA Damage Response Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global DNA Damage Response Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global DNA Damage Response Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global DNA Damage Response Drugs Market Share by Regions (2016-2021)
    Table 10. Global DNA Damage Response Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global DNA Damage Response Drugs Market Share by Regions (2022-2027)
    Table 12. DNA Damage Response Drugs Market Trends
    Table 13. DNA Damage Response Drugs Market Drivers
    Table 14. DNA Damage Response Drugs Market Challenges
    Table 15. DNA Damage Response Drugs Market Restraints
    Table 16. Global DNA Damage Response Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global DNA Damage Response Drugs Market Share by Players (2016-2021)
    Table 18. Global Top DNA Damage Response Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Damage Response Drugs as of 2020)
    Table 19. Ranking of Global Top DNA Damage Response Drugs Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by DNA Damage Response Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players DNA Damage Response Drugs Product Solution and Service
    Table 23. Date of Enter into DNA Damage Response Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global DNA Damage Response Drugs Revenue Market Share by Type (2016-2021)
    Table 27. Global DNA Damage Response Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global DNA Damage Response Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global DNA Damage Response Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global DNA Damage Response Drugs Revenue Market Share by Application (2016-2021)
    Table 31. Global DNA Damage Response Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global DNA Damage Response Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America DNA Damage Response Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America DNA Damage Response Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America DNA Damage Response Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America DNA Damage Response Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America DNA Damage Response Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe DNA Damage Response Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe DNA Damage Response Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe DNA Damage Response Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe DNA Damage Response Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe DNA Damage Response Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific DNA Damage Response Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific DNA Damage Response Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific DNA Damage Response Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific DNA Damage Response Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific DNA Damage Response Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America DNA Damage Response Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America DNA Damage Response Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America DNA Damage Response Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America DNA Damage Response Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America DNA Damage Response Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa DNA Damage Response Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa DNA Damage Response Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa DNA Damage Response Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa DNA Damage Response Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa DNA Damage Response Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. AbbVie Inc Company Details
    Table 64. AbbVie Inc Business Overview
    Table 65. AbbVie Inc DNA Damage Response Drugs Product
    Table 66. AbbVie Inc Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 67. AbbVie Inc Recent Development
    Table 68. AstraZeneca Company Details
    Table 69. AstraZeneca Business Overview
    Table 70. AstraZeneca DNA Damage Response Drugs Product
    Table 71. AstraZeneca Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 72. AstraZeneca Recent Development
    Table 73. Bayer Company Details
    Table 74. Bayer Business Overview
    Table 75. Bayer DNA Damage Response Drugs Product
    Table 76. Bayer Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 77. Bayer Recent Development
    Table 78. BeiGene Company Details
    Table 79. BeiGene Business Overview
    Table 80. BeiGene DNA Damage Response Drugs Product
    Table 81. BeiGene Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 82. BeiGene Recent Development
    Table 83. Clovis Oncology Company Details
    Table 84. Clovis Oncology Business Overview
    Table 85. Clovis Oncology DNA Damage Response Drugs Product
    Table 86. Clovis Oncology Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 87. Clovis Oncology Recent Development
    Table 88. Debiopharm Company Details
    Table 89. Debiopharm Business Overview
    Table 90. Debiopharm DNA Damage Response Drugs Product
    Table 91. Debiopharm Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 92. Debiopharm Recent Development
    Table 93. Eli Lilly and Company Company Details
    Table 94. Eli Lilly and Company Business Overview
    Table 95. Eli Lilly and Company DNA Damage Response Drugs Product
    Table 96. Eli Lilly and Company Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 97. Eli Lilly and Company Recent Development
    Table 98. GlaxoSmithKline Company Details
    Table 99. GlaxoSmithKline Business Overview
    Table 100. GlaxoSmithKline Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 101. GlaxoSmithKline Recent Development
    Table 102. Merck Company Details
    Table 103. Merck Business Overview
    Table 104. Merck DNA Damage Response Drugs Product
    Table 105. Merck Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 106. Merck Recent Development
    Table 107. NMS Group SpA Company Details
    Table 108. NMS Group SpA Business Overview
    Table 109. NMS Group SpA DNA Damage Response Drugs Product
    Table 110. NMS Group SpA Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 111. NMS Group SpA Recent Development
    Table 112. Onxeo Company Details
    Table 113. Onxeo Business Overview
    Table 114. Onxeo DNA Damage Response Drugs Product
    Table 115. Onxeo Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 116. Onxeo Recent Development
    Table 117. Pfizer Company Details
    Table 118. Pfizer Business Overview
    Table 119. Pfizer DNA Damage Response Drugs Product
    Table 120. Pfizer Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 121. Pfizer Recent Development
    Table 122. Repare Therapeutics Company Details
    Table 123. Repare Therapeutics Business Overview
    Table 124. Repare Therapeutics DNA Damage Response Drugs Product
    Table 125. Repare Therapeutics Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 126. Repare Therapeutics Recent Development
    Table 127. Sierra Oncology Company Details
    Table 128. Sierra Oncology Business Overview
    Table 129. Sierra Oncology DNA Damage Response Drugs Product
    Table 130. Sierra Oncology Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 131. Sierra Oncology Recent Development
    Table 132. Zentalis Pharmaceuticals Company Details
    Table 133. Zentalis Pharmaceuticals Business Overview
    Table 134. Zentalis Pharmaceuticals DNA Damage Response Drugs Product
    Table 135. Zentalis Pharmaceuticals Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
    Table 136. Zentalis Pharmaceuticals Recent Development
    Table 137. Research Programs/Design for This Report
    Table 138. Key Data Information from Secondary Sources
    Table 139. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global DNA Damage Response Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Lynparza Features
    Figure 3. Talzenna Features
    Figure 4. Zejula Features
    Figure 5. Rubraca Features
    Figure 6. Global DNA Damage Response Drugs Market Share by Application: 2020 VS 2027
    Figure 7. Ovarian Cancer Case Studies
    Figure 8. Breast Cancer Case Studies
    Figure 9. Pancreatic Cancer Case Studies
    Figure 10. Prostate Cancer Case Studies
    Figure 11. DNA Damage Response Drugs Report Years Considered
    Figure 12. Global DNA Damage Response Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global DNA Damage Response Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global DNA Damage Response Drugs Market Share by Regions: 2020 VS 2027
    Figure 15. Global DNA Damage Response Drugs Market Share by Regions (2022-2027)
    Figure 16. Global DNA Damage Response Drugs Market Share by Players in 2020
    Figure 17. Global Top DNA Damage Response Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Damage Response Drugs as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by DNA Damage Response Drugs Revenue in 2020
    Figure 19. Global DNA Damage Response Drugs Revenue Market Share by Type (2016-2021)
    Figure 20. Global DNA Damage Response Drugs Revenue Market Share by Type (2022-2027)
    Figure 21. North America DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America DNA Damage Response Drugs Market Share by Type (2016-2027)
    Figure 23. North America DNA Damage Response Drugs Market Share by Application (2016-2027)
    Figure 24. North America DNA Damage Response Drugs Market Share by Country (2016-2027)
    Figure 25. United States DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe DNA Damage Response Drugs Market Share by Type (2016-2027)
    Figure 29. Europe DNA Damage Response Drugs Market Share by Application (2016-2027)
    Figure 30. Europe DNA Damage Response Drugs Market Share by Country (2016-2027)
    Figure 31. Germany DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific DNA Damage Response Drugs Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific DNA Damage Response Drugs Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific DNA Damage Response Drugs Market Share by Region (2016-2027)
    Figure 41. China DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America DNA Damage Response Drugs Market Share by Type (2016-2027)
    Figure 49. Latin America DNA Damage Response Drugs Market Share by Application (2016-2027)
    Figure 50. Latin America DNA Damage Response Drugs Market Share by Country (2016-2027)
    Figure 51. Mexico DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa DNA Damage Response Drugs Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa DNA Damage Response Drugs Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa DNA Damage Response Drugs Market Share by Country (2016-2027)
    Figure 57. Turkey DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. AbbVie Inc Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 61. AstraZeneca Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 62. Bayer Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 63. BeiGene Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 64. Clovis Oncology Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 65. Debiopharm Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 66. Eli Lilly and Company Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 67. GlaxoSmithKline Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 68. Merck Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 69. NMS Group SpA Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 70. Onxeo Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 71. Pfizer Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 72. Repare Therapeutics Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 73. Sierra Oncology Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 74. Zentalis Pharmaceuticals Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie Inc
AstraZeneca
Bayer
BeiGene
Clovis Oncology
Debiopharm
Eli Lilly and Company
GlaxoSmithKline
Merck
NMS Group SpA
Onxeo
Pfizer
Repare Therapeutics
Sierra Oncology
Zentalis Pharmaceuticals
Frequently Asked Questions
DNA Damage Response Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
DNA Damage Response Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
DNA Damage Response Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports